AGF Management Ltd. Invests $796,000 in Henry Schein, Inc. (NASDAQ:HSIC)

AGF Management Ltd. purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 11,499 shares of the company's stock, valued at approximately $796,000.

A number of other large investors have also made changes to their positions in HSIC. Clarkston Capital Partners LLC lifted its position in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock valued at $101,900,000 after buying an additional 71,560 shares in the last quarter. Nuance Investments LLC lifted its position in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. lifted its position in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Henry Schein during the 3rd quarter valued at about $515,000. Finally, Private Management Group Inc. lifted its position in shares of Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after buying an additional 18,882 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

Shares of HSIC traded down $1.16 during mid-day trading on Wednesday, hitting $70.84. 2,352,243 shares of the stock were exchanged, compared to its average volume of 1,507,564. The company has a market cap of $8.80 billion, a PE ratio of 29.15, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The firm has a 50-day moving average of $74.85 and a two-hundred day moving average of $72.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Remove Ads

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.66 EPS. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Barrington Research reaffirmed an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target on the stock. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Finally, UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.